Bioprocess buffer salts sales will expand through 2036, with GMP / biopharma grade at 52.0% of grade sales, phosphate salts at 38.0% within the salt type segment and chromatography buffers at 34.0% of the application category in 2026. The market is projected to record a 9.6% CAGR between 2026 and 2036.